Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

C. Faivre-Finn; D. R. Spigel; S. Senan; C. J. Langer; D. Raben; B. Perez; M. Özgüroğlu; D. Daniel; A. Villegas; D. Vicente; R. Hui; S. Murakami; L. Paz-Ares; L. Poole; C. Wadsworth; P. A. Dennis; S. J. Antonia

doi:https://doi.org/10.1093/annonc/mdy291

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

C. Faivre-Finn, D. R. Spigel, S. Senan, C. J. Langer, D. Raben, B. Perez, M. Özgüroğlu, D. Daniel, A. Villegas, D. Vicente, R. Hui, S. Murakami, L. Paz-Ares, L. Poole, C. Wadsworth, P. A. Dennis, S. J. Antonia

Radiation Oncology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	viii488
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy291
Publication status	Published - 1 Oct 2018

Access to Document

https://doi.org/10.1093/annonc/mdy291

Cite this

Faivre-Finn, C., Spigel, D. R., Senan, S., Langer, C. J., Raben, D., Perez, B., Özgüroğlu, M., Daniel, D., Villegas, A., Vicente, D., Hui, R., Murakami, S., Paz-Ares, L., Poole, L., Wadsworth, C., Dennis, P. A., & Antonia, S. J. (2018). Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii488. https://doi.org/10.1093/annonc/mdy291

@article{2e46bb0eddcd4f80b148b7e129ef1b7c,

title = "Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC",

author = "C. Faivre-Finn and Spigel, {D. R.} and S. Senan and Langer, {C. J.} and D. Raben and B. Perez and M. {\"O}zg{\"u}roğlu and D. Daniel and A. Villegas and D. Vicente and R. Hui and S. Murakami and L. Paz-Ares and L. Poole and C. Wadsworth and Dennis, {P. A.} and Antonia, {S. J.}",

year = "2018",

month = oct,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdy291",

language = "English",

volume = "29",

pages = "viii488",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Faivre-Finn, C, Spigel, DR, Senan, S, Langer, CJ, Raben, D, Perez, B, Özgüroğlu, M, Daniel, D, Villegas, A, Vicente, D, Hui, R, Murakami, S, Paz-Ares, L, Poole, L, Wadsworth, C, Dennis, PA & Antonia, SJ 2018, 'Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii488. https://doi.org/10.1093/annonc/mdy291

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC. / Faivre-Finn, C.; Spigel, D. R.; Senan, S. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii488.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

AU - Faivre-Finn, C.

AU - Spigel, D. R.

AU - Senan, S.

AU - Langer, C. J.

AU - Raben, D.

AU - Perez, B.

AU - Özgüroğlu, M.

AU - Daniel, D.

AU - Villegas, A.

AU - Vicente, D.

AU - Hui, R.

AU - Murakami, S.

AU - Paz-Ares, L.

AU - Poole, L.

AU - Wadsworth, C.

AU - Dennis, P. A.

AU - Antonia, S. J.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081531617&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/annonc/mdy291

DO - https://doi.org/10.1093/annonc/mdy291

M3 - Article

C2 - 32137260

SN - 0923-7534

VL - 29

SP - viii488

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

Access to Document

Other files and links

Cite this